First developed more than four decades ago as a biological research technique to amplify nucleic acids, polymerase chain reaction (PCR) technology still has untapped potential, with many exciting ...

PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...

At the start of the SARS-CoV-2 pandemic people who felt unwell had to join long queues for lab-based PCR tests and then wait for two days to learn if they were infected with the COVID-19 virus or not.

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.